Preview

HIV Infection and Immunosuppressive Disorders

Advanced search

FEATURES OF CONCOMITANT HIV/TUBERCULOSIS DISEASES WITH FATAL OUTCOMES

https://doi.org/10.22328/2077-9828-2019-11-4-70-78

Abstract

Abstract. The issues of concomitant pathology of HIV infection and tuberculosis are becoming increasingly relevant in the period of improving the epidemiological situation of tuberculosis. HIV-associated tuberculosis is given more attention due to the peculiarities of the processes characterized by generalization, progression and high lethal outcomes. Objective. The purpose of this work is to study the characteristics of tuberculosis in patients with HIV infection in a region with a high prevalence of HIV infection with fatal outcomes. Materials and methods. For a comparative analysis, depending on the outcome of the disease, 2 groups were formed: 1st group — 70 patients with tuberculosis and HIV infection (tuberculosis/HIV) who died within a month after admission to the tuberculosis hospital (main group), 2nd group — 70 tuberculosis/HIV patients were discharged from the hospital with improvement (comparison group). All patients received treatment in accordance with clinical guidelines. In statistical calculations, the Pearson c2-criterion or the c2-criterion with the Yeats correction with the number of degrees of freedom f=1 (f=(r–1)×(c–1)) was used. The level of significance was taken as a value of 0,05 or less. Results. In the first group, tuberculosis was more often detected upon admission to non-main hospitals (c2=5,28; р=0,0216), diagnosed with pneumonia (c2=9,46 р=0,0021) in the absence of fluorography in the current year. Mortality was more common in people under the age of 30 years who had no family (c2=18,72; p=0,00001) who were in prison (c2=7,96; p=0,0048) and led an antisocial lifestyle. An analysis of the manifestations of tuberculosis revealed no differences that determine the lethal outcome. The difficulty of diagnosing tuberculosis occurred when the CD4+ level was less than 300 cells. Comorbidity of tuberculosis and HIV infection is characterized by a commonality of many clinical manifestations regardless of the outcome. The presence of burdened social status increases the likelihood of dying with concomitant HIV/TB diseases.

About the Authors

E. A. Borodulina
Samara State Medical University
Russian Federation
Samara, Russia


E. S. Vdoushkina
Samara State Medical University
Russian Federation
Samara, Russia


A. N. Kuznetsova
Samara State Medical University
Russian Federation
Samara, Russia


E. P. Gladunova
Samara State Medical University
Russian Federation
Samara, Russia


References

1. Vаsilyevа I.А., Belilovsky E.M., Borisov S.E., Sterlikov S.А. Incidence, mortality and prevalence as indicatorsof tuberculosis burden in who regions, countries of the world and the russian federation. Part 2. Tuberculosis mortality. Tuberculosis and Lung Diseases, 2017, Vol. 95, No. 7, pp. 8–16 (In Russ.). DOI: 10.21292/2075-1230-2017-95-7-8-16.

2. Pokrovskij V.V., Yurin O.G. and Kravchenko A.V. National Guidelines for Dispensary Observation and Treatment of Patients with HIV Infection. Epidemiology and Infectious Diseases. Current Items. 2016, S6, annex (In Russ.).

3. Ermak T.N. Opportunistic (secondary) lesions in patients with HIV infection. Introductory lecture. Lectures on HIV infection, еd. V. V. Pokrovskij. Moscow: Publishing house GEOTAR-Media, 2018, рр. 134–138 (In Russ.).

4. Mikhaylova N.R., Ermak T.N. Secondary diseases in HIV-positive patients: specificities of epidemic process in penitentiary institutions. Infectious Diseases, 2013, Vol. 11, No. 4, pp. 52–59 (In Russ.).

5. Belyakov N.A., Rassokhin V.V., Trofimova T.N., Stepanova E.V., Panteleev A.M., Leonova O.N., Buzunova S.A., Konovalova N.V., Milichkina A.M., Totolyan A.A. Advanced and comorbid HIV cases in Russia. HIV Infection and Immunosuppressive Disorders, 2016, Vol. 8, No. 3, pp. 9–25. (In Russ.).

6. Starshinova A.A., Panteleev A.M., Vasilyeva E.V., Manina V.V., Pavlova M.V., Sapozhnikova N.V. Application of modern immunological methods in the diagnosis of tuberculosis in HIV-infected patients. Journal Infectology, 2015, Vol. 7, No. 3, pp. 126–130. (In Russ.).

7. Podlekareva D.N., Efsen A.M.W., Lundgren J.D., Kirk O., Schultze A., Mocroft A., Post F.A., Skrahina A.M., Panteleev A., Furrer H., Miller R.F., Losso M.H., Toibaro J., Miro J.M., Vassilenko A., Girardi E., Bruyand M., Obel N. Tuberculosis-related mortality in people living with HIV in Еurope and Latin America: an international cohort study // The Lancet HIV. 2016. Vol. 3. No. 3. Р. e120-e131. DOI: 10.1016/S2352-3018(15)00252-0.

8. Efsen A.M.W., Podlekareva D.N., Lundgren J.D., Kirk O., Schultze A., Mocroft A., Post F.A., Panteleev A., Furrer H., Miller R.F., Losso M.H., Toibaro J., Skrahin A., Miro J.M., Caylà J.A., Girardi E., Bruyand M., Obel N. Major challenges in clinical management of TB/HIV coinfected patients in Eastern Europe compared with Western Europe and Latin America // Plos one. 2015. Vol. 10, No. 12. pp. e0145380. DOI: 10.1371/journal.pone.0145380

9. Karpov I., Vassilenko A., Skrahina A., Klimuk D., Skrahin A., Kondratenko O., Zalutskaya A., Bondarenko V., Mitsura V., Kozorez E., Tumash O., Suetnov O., Paduto D., Iljina V., Kummik T., Bolokadze N., Mshvidobadze K., Lanchava N., Goginashvili L., Mikiashvili L. et al. Management of MDR-TB in HIV co-infected patients in Eastern Europe: results from the TB: HIV study // Journal of Infection. 2018. Vol. 76. No. 1. Р. 44–54. DOI: 10.1016/j.jinf.2017.10.007.

10. Mansfeld M., Kirk O., Lundgren J., Efsen A., Podlekareva D., Skrahina A., Shepherd L., Schultze A., Mocroft A., Panteleev A., Miller R., Miro J., Zeltina I., Tetradov S., Furrer H., Grzeszczuk A., Bolokadze N., Matteelli A., Post F., Losso M.H. et al. Major differences in organization and availability of health care and medicines for HIV/TB coinfected patients across Europe // HIV Medicine. 2015. Vol. 16. No. 9. Р. 544–552. DOI: 10,1111/hiv.12256.

11. Mishin V.Yu., Mishina A.V., Levchenko M.V., Sobkin A.L., Ergeshov A.E. Tuberculosis and HIV coinfection. Consilium Medicum, 2017, Vol. 19, No. 11, pp. 59–63 (In Russ.). DOI: 10.26442/2075-1753_19.11.59–63.

12. Velikaya O.V., Barkovskaya L.V., Khoroshilova N.E., Lushnikova A.V. Тuberculosis and the hiv infection in Voronezh region. System analysis and management in biomedical systems, 2017, Vol. 16, No. 3, pp. 708–711 (In Russ.).

13. Davydkin I.L., Osadchuk A.M., Borodulina E.A., Gritsenko T.A. Infiltrative lung tuberculosis, peptic ulcer disease and HIV infection (comorbidity and multimorbidity of diseases). Science & Innovations in Medicine, 2016, No. 1 (1), pp. 19–24. (In Russ.).

14. Borodulina E.A., Matkina T.N., Vdoushkina E.S. Causes of death of patients suffering from HIV-infection and tuberculosis. Tuberculosis and Lung Diseases, 2015, No. 5, pp. 44–45 (In Russ.).

15. Bulekov I.S., Samarina A.V. Specificities of care provision to HIV-infected pregnant drug-abusing women. HIV Infection and Immunosuppressive Disorders, 2012, Vol. 4, No. 1, pp. 32–41 (In Russ.).

16. Zyryanova T.V., Amitina T.R., Poddubnaya L.V., Fedorova M.V. Tuberculosis and HIV-infection — concurrent conditions inspecialized TB hospital. Tuberculosis and Lung Diseases, 2015, No. 6, pp. 66–67 (In Russ.).

17. Mordyk A.V., Ivanova O.G., Sitnikova S.V. Tuberculosis combined with HIV infection: causes of failures in the treatment. Omsk Scietntific Bulletin, 2015, No. 2 (144), pp. 23–26 (In Russ.).

18. Manina V.V., Starshinova A.A., Panteleev A.M., Zhuravlev V.Yu., Yakunova O.A., Yablonsky P.K. The results of immunological tests In Vitro and In Vivo in the diagnosis of tuberculosis in patients with HIV infection depending on the level of immunosuppression. Tuberculosis and socially significant diseases, 2016, No. 1, pp. 37–42 (In Russ.).

19. Vinogradova T.N., Panteleyeva O.V., Piskarev I.G. et al. HIV prevalence among injection drug users in saint Petersburg. Part 2. knowledge about HIV and abasement of help. HIV Infection and Immunosuppressive Disorders, 2016, Vol. 8. No. 2, pp. 23–32 (In Russ.).

20. Zimina V.N., Kravchenko A.V., Batyrov F.A. et al. Generalized tuberculosis in patients with HIV infection at the stage of secondary diseases. Infectious Diseases, 2010, Vol. 8. No. 3, pp. 5–8 (In Russ.).

21. Podlekareva D.N., Werlinrud A.M., Lundgren J.D., Kirk O., Panteleev A.M., Grint D., Mocroft A., Post F.A., Miro J.M., Bruyand M., Furrer H., Obel N., Girardi E., Vasilenko A., Losso M.H., Arenas-Pinto A., Caylá J., Rakhmanova A., Zeltina I. Short- and long-term mortality and causes of death in HIV/Tuberculosis patients in Europe // European Respiratory Journal. 2014. Vol. 43. No. 1. Р. 166–177. DOI: 10.1183/09031936.00138712.

22. Starshinova A., Zhuravlev V., Dovgaluk I., Panteleev A., Zinchenko U., Istomina E., Pavlova M., Yablonskiy P. Results of retrospective-prospective comparison study of different immunologic tests in diagnosis of tuberculosis infection // European Respiratory Journal. 2018. Vol. 52, No. S62. Р. 2966.

23. Jarrin I., Del Amo J., Pantazis N., Dalmau J., Blanco J., Martinez-Picado J., Phillips A.N., Olson A., Porter K., Mussini C., Boufassa F., Costagliola D., Kelleher T., Cooper D., Finlayson R., Bloch M., Ramacciotti T., Gelgor L., Smith D., Zangerle R. et al. Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ t-cell recovery once HIV-1 suppression is achieved? // AIDS. 2015. Vol. 29. No. 17. Р. 2323–2333. DOI: 10.1097/QAD.0000000000000805.

24. Puzyreva L.V., Mordyk A.V., Rudenko S.A. et al. The analysis of death outcomes in patients of antituberculosis dispensary: tuberculosis in combination with HIV infection. Medical news of the North Caucasus, 2017, Vol. 12, No. 2, pp. 169–172 (In Russ.). DOI: 10.14300/mnnc.2017.12047.

25. Azovtseva O.V., Trofimova T.S., Arkhipov G.S., Ogurtsova S.V., Panteleev A.M., Belyakov N.A. Letal outcomes in patients with HIV infection, parallels with adequacy of diagnostics, dispenser and treatment. HIV Infection and Immunosuppressive Disorders, 2018, Vol. 10, No. 3, pp. 90–101 (In Russ.).


Review

For citations:


Borodulina E.A., Vdoushkina E.S., Kuznetsova A.N., Gladunova E.P. FEATURES OF CONCOMITANT HIV/TUBERCULOSIS DISEASES WITH FATAL OUTCOMES. HIV Infection and Immunosuppressive Disorders. 2019;11(4):70-78. (In Russ.) https://doi.org/10.22328/2077-9828-2019-11-4-70-78

Views: 1131


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2077-9828 (Print)